New simplera sync™ sensor for the minimed™ 780g system now fda approved

Latest approval expands medtronic cgm portfolio in the u.s. galway, ireland , april 18, 2025 /prnewswire/ -- medtronic plc (nyse: mdt), a global leader in healthcare technology, today announced the u.s. food and drug administration (fda) approval for the simplera sync™ sensor for use with the minimed™ 780g system. with this approval, the minimed™ 780g system now offers more flexibility for users of the company's most advanced insulin delivery system featuring meal detection™ technology with both the guardian™ 4 sensor and simplera sync™ sensor.
MDT Ratings Summary
MDT Quant Ranking